Journals / Şişli Etfal Hastanesi Tıp Bülteni / 2018 / Cilt: 52 - Sayı: 4

Surgical Treatment in Papillary Thyroid Microcarcinoma

Pages
244–248
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We have also discussed surgical strategiesas the accepted the first-line treatment in patients with PTMC.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Despite the notable increasing incidence of papillary thyroid microcarcinoma (PTMC), the optimal treatment of the patientswith PTMC remains controversial.
📊
Key Findings & Data:Although the 2015 revised American Thyroid Association guideline recommendshemithyroidectomy as the first-line treatment, active surveillance has also been discussed and accepted as another approachfor the patients with PTMC.
💡
Conclusion & Impact:We have also discussed surgical strategiesas the accepted the first-line treatment in patients with PTMC.
🔬Design:Review & Systematic Survey
📍Scope:2015 Verileri
⚙️Variables:Domain Parameters

Özet

Despite the notable increasing incidence of papillary thyroid microcarcinoma (PTMC), the optimal treatment of the patientswith PTMC remains controversial. Because of no consensus about its treatment, the suggested treatment varies from activesurveillance alone to total thyroidectomy. Although the 2015 revised American Thyroid Association guideline recommendshemithyroidectomy as the first-line treatment, active surveillance has also been discussed and accepted as another approachfor the patients with PTMC. However, the same guideline does not recommend fine needle aspiration biopsy for nodules sized<1 cm, even it is suspicious. In such situation, neither active surveillance nor hemithyroidectomy could be discussed, with a lackof objective cytologic data about the nodules sized <1 cm. In this situation, the decision to perform FNAB to the nodules <1 cmin size depends on the performer of the thyroid ultrasonography.In this invited review, we have discussed the diagnosis and prognostic factors for PTMCs. We have also discussed surgical strategiesas the accepted the first-line treatment in patients with PTMC.

🔖

Cite This Article

TUNCA, F., SORMAZ, İ. C., İŞCAN, A. Y., ŞENYÜREK, Y. G. (2018). Surgical Treatment in Papillary Thyroid Microcarcinoma. Şişli Etfal Hastanesi Tıp Bülteni, Cilt: 52 - Sayı: 4, 244–248. https://ajindex.com/articles/363992

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. A Snapshot of Thyroid Cancer: Incidence and mortality.National Cancer Institute, Bethesda, MD, 2014. Available at: https://www. cancer.gov/research/progress/snapshots/ thyroid
  2. Davies L, Welch HG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg 2014;140:317–22
  3. Hedinger CE, Williams ED, World Health Organization. Histological typing of thyroid tumours. 2nd ed. Berlin: Springer; 1993. p. 66
  4. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1–133
  5. Miyauchi A, Ito Y, Oda H. Insights into the Management of Papillary Microcarcinoma of the Thyroid. Thyroid 2018;28:23–31
  6. Ito Y, Miyauchi A, Oda H. Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials. Eur J Surg Oncol 2018;44:307–315
  7. Yu XM, Lloyd R, Chen H. Current treatment of papillary thyroid microcarcinoma. Adv Surg 2012;46:191–203
  8. Kwon H, Oh HS, Kim M, Park S, Jeon MJ, Kim WG, et al. Active Surveillance for Patients With Papillary Thyroid Microcarcinoma: A Single Center's Experience in Korea. J Clin Endocrinol Metab 2017;102:1917–25
  9. Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, et al. Extent of surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg 2014;260:601–5
  10. Wang TS, Goffredo P, Sosa JA, Roman SA. Papillary thyroid microcarcinoma: an over-treated malignancy? World J Surg 2014;38:2297–303
  11. Hauch A, Al-Qurayshi Z, Randolph G, Kandil E. Total thyroidectomy is associated with increased risk of complications for lowand high-volume surgeons. Ann Surg Oncol 2014;21:3844–52
  12. Rosato L, Pacini F, Panier Suffat L, Mondini G, Ginardi A, Maggio M, et al. Post-thyroidectomy chronic asthenia: self-deception or disease? Endocrine 2015;48:615–20
  13. Miyauchi A. Clinical Trials of Active Surveillance of Papillary Microcarcinoma of the Thyroid. World J Surg 2016;40:516–22
  14. Musholt TJ, Fottner C, Weber MM, Eichhorn W, Pohlenz J, Musholt PB, et al. Detection of papillary thyroid carcinoma by analysis of BRAF and RET/PTC1 mutations in fine-needle aspiration biopsies of thyroid nodules. World J Surg 2010;34:2595–603
  15. Li F, Chen G, Sheng C, Gusdon AM, Huang Y, Lv Z